Table 3 Study measures in the RCT-Rits study
Name of scale | References | Source | Validated | Time of assessment |
|---|---|---|---|---|
AAR-R = Any Adverse Reactions-Revised | (Bejerot et al. 2023) [47] | Interviewer assessed | no | Baseline Endpoint I Endpoint II |
CGI-S = Clinical Global Impression-Severity scale | (Guy, 1976) [56] | Interviewer assessed | yes | Baseline Endpoint I Endpoint II |
CGI-I = Clinical Global Impression-Improvement scale | (Guy, 1976) [56] | Interviewer assessed | yes | Endpoint I Endpoint II |
CGI-I = Clinical Global Impression-Improvement scale | (Guy, 1976) [56] | Informant-report | no | Week 2 Week 7 Endpoint I Endpoint II |
FTF-Brief = Five to Fifteen – Brief rating scale | (Lugnegård & Bejerot 2019) [65] | Informant-report | yes | Between week 12 and 24 |
Level 1 Cross-cutting symptom measure of global symptom severity (CCSM) | (APA, 2013) [58] | Self-report | yes | Baseline Endpoint I Endpoint II |
MAP-SR = The Motivation and Pleasure – Self Report | (Llerena et al. 2013) [63] | Self-report | yes | Baseline Endpoint I Endpoint II |
PANSS = Positive and Negative Syndrome Scale | (Kay et al. 1987) [52] | Interviewer assessed | yes | Baseline Endpoint I Endpoint II |
PGE = Patient’s Global Evaluation (of severity improvement) | (Zohar & Judge, 1996) [57] | Self-report | no | Week 2 Week 7 Endpoint I Endpoint II |
Adverse events, open check-up questions | Â | Interviewer assessed | no | Week 2 Week 7 Endpoint I Endpoint II |
PSP = Personal and Social Performance Scale | (Morosini et al. 2000) [55] | Interviewer assessed | yes | Baseline Endpoint I Endpoint II |
SNS = Self-assessment of Negative Symptoms | (Dollfus et al. 2016) [64] | Self-report | yes | Endpoint I |
VAS health = Visual Analogue Scale for measuring wellbeing |  | Self-report | no | Baseline Endpoint I Endpoint II |
Qualitative interview (optional) | Â | Interviewer assessed | Â | Between week 12 and 24 |